Ncino (NASDAQ:NCNO) Azioni

NCINO INC

Ncino

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

Munich,,Bavaria,,Germany,-,March,31,2023:,Unifirst,Offers,Top-quality

Equities

Market Summary

News

Pre-Market Outlook

Markets

Trading Ideas

NCNO

SPWH

Le trimestrali e le previsioni che muovono il mercato. Analizziamo i risultati, le reazioni degli investitori e le prossime mosse.

UniFirst, BlackBerry e altri 3 titoli chiave da monitorare: cosa aspettarsi oggi?

Tesla Rival XPeng Eyes $13.8 Billion Investment In Humanoid Robots, Says Chinese State Media

ALLR

ULBI

XPEV

Nonostante le previsioni negative sui mercati, alcune società hanno registrato performance promettenti. Ecco di chi si tratta.

XPeng, Ultralife e altre 3 azioni da tenere d&#39;occhio in vista di martedì

Ncino Inc

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

FUFU

BitFuFu Bitcoin Production In June Increased 11.3% Month Over Month To 445

Management

Allarity Therapeutics Appoints Jeff Ervin As CFO; Succeeds Alexander Epshinsky

<h3>Gainers</h3>
<ul>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock rose 41.4% to $0.32 during Monday's pre-market session. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) shares moved upwards by 15.53% to $2.9. The company's market cap stands at $18.7 million. </li>
<li>Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) stock moved upwards by 12.39% to $1.72. The market value of their outstanding shares is at $3.6 million. </li>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) shares rose 9.97% to $4.4. The market value of their outstanding shares is at $17.6 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) stock increased by 9.37% to $3.03. The company's market cap stands at $12.6 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares rose 9.35% to $7.77. The market value of their outstanding shares is at $3.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) stock decreased by 11.2% to $18.95 during Monday's pre-market session. The market value of their outstanding shares is at $580.1 million. </li>
<li>Cricut (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) shares fell 10.41% to $6.46. The company's market cap stands at $1.5 billion. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares fell 8.72% to $1.46. The company's market cap stands at $467.5 million. </li>
<li>Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares declined by 6.46% to $294.98. The market value of their outstanding shares is at $1.0 trillion. </li>
<li>Cenntro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENN#NASDAQ">CENN</a>) shares decreased by 6.2% to $0.7. The market value of their outstanding shares is at $35.9 million. </li>
<li>Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) stock decreased by 5.53% to $4.62. The market value of their outstanding shares is at $108.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ALUR

AMST

CENN

CRCT

MULN

NWTN

PLCE

SCVL

TSLA

UCAR

VLCN

XELB

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Canaccord Genuity analyst Joseph Vafi initiated coverage on Chime Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) with a Buy rating and announced a price target of $40. Chime Financial shares closed at $31.32 on Thursday. <a href="https://www.benzinga.com/quote/chym/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CICC initiated coverage on Rockwell Automation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with an Outperform rating and announced a price target of $381. Rockwell Automation shares closed at $347.07 on Thursday. <a href="https://www.benzinga.com/quote/ROK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Blayne Curtis initiated coverage on Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) with a Buy rating and announced a price target of $60. SanDisk shares closed at $46.41 on Thursday. <a href="https://www.benzinga.com/quote/SNDK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Sheila Kahyaoglu initiated coverage on Voyager Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYG#NYSE">VOYG</a>) with a Buy rating and announced a price target of $50. Voyager Technologies shares closed at $42.35 on Thursday. <a href="https://www.benzinga.com/quote/VOYG/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ROK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="558" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07080557/image-62-1024x558.png" alt="" class="wp-image-974661" style="width:650px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07080557/image-62-1024x558.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07080557/image-62-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07080557/image-62-768x419.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07080557/image-62.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Initiation

Analyst Ratings

CHYM

SNDK

VOYG

This Rockwell Automation Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday

<h3>Gainers</h3>
<ul>
<li>Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) stock moved upwards by 171.6% to $27.3 during Monday's pre-market session. The market value of their outstanding shares is at $5.4 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) shares rose 42.34% to $5.58. The company's market cap stands at $12.4 million. </li>
<li>Cogent Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) shares rose 17.28% to $8.89. The market value of their outstanding shares is at $863.0 million. </li>
<li>Apogee Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) shares moved upwards by 16.24% to $55.17. The market value of their outstanding shares is at $2.7 billion. </li>
<li>KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) stock rose 15.6% to $13.85. The market value of their outstanding shares is at $595.5 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) shares increased by 14.54% to $0.46. The market value of their outstanding shares is at $25.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jasper Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) stock declined by 71.8% to $1.91 during Monday's pre-market session. The company's market cap stands at $101.6 million. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock declined by 14.49% to $2.42. The market value of their outstanding shares is at $7.8 million. </li>
<li>Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) shares fell 9.82% to $1.93. The market value of their outstanding shares is at $392.6 million. </li>
<li>Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) shares decreased by 8.84% to $10.11. The company's market cap stands at $6.3 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares declined by 8.26% to $0.85. The company's market cap stands at $3.4 million. </li>
<li>VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) stock declined by 8.11% to $0.68. The company's market cap stands at $76.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APGE

ARTL

CGTX

COGT

INDP

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

KALV

LIXT

SONN

VNRX

WINT

12 Health Care Stocks Moving In Monday's Pre-Market Session

AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory Automation
Partnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and More
SAN DIEGO, CALIFORNIA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / July 7, 2025 / Ainos, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMDW#NASDAQ">AIMDW</a>) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced a five-year distribution partnership with Solomon Technology Corporation, a leader in machine vision, industrial AI, and smart automation. The partnership aims to fast-track Ainos' AI Nose platform into Asia's key manufacturing sectors: semiconductors, petrochemicals, autonomous mobile robots (AMRs), and more.

AIMD

AIMDW

Ainos Announces 5-Yr Distribution Partnership With Solomon Technology To Fast-Track Ainos' AI Nose Platform Into Asia's Key Manufacturing Sectors

<h3>Gainers</h3>
<ul>
<li>Eshallgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHGO#NASDAQ">EHGO</a>) stock rose 25.6% to $1.08 during Monday's pre-market session. The market value of their outstanding shares is at $23.1 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock increased by 12.15% to $3.69. The company's market cap stands at $112.2 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock rose 11.77% to $0.23. The market value of their outstanding shares is at $29.8 million. </li>
<li>Quhuo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>) stock rose 11.53% to $1.45. The market value of their outstanding shares is at $116.6 million. </li>
<li>Royalty Management Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMCO#NASDAQ">RMCO</a>) stock rose 8.77% to $1.73. The market value of their outstanding shares is at $23.7 million. </li>
<li>FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) shares rose 8.43% to $0.72. The company's market cap stands at $6.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares decreased by 18.2% to $0.16 during Monday's pre-market session. The market value of their outstanding shares is at $5.2 million. </li>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock declined by 16.61% to $0.85. The company's market cap stands at $78.2 million. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) stock fell 7.77% to $7.01. The market value of their outstanding shares is at $160.9 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares declined by 5.8% to $0.32. The market value of their outstanding shares is at $5.8 million. </li>
<li>Aebi Schmidt Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEBI#NASDAQ">AEBI</a>) shares declined by 5.22% to $12.9. The company's market cap stands at $1.0 billion. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) shares declined by 4.98% to $3.63. The company's market cap stands at $26.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEBI

EHGO

HTOO

HUHU

NEOV

RMCO

SCWO

YGMZ

ZBAI

12 Industrials Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares rose 46.3% to $2.97 during Monday's pre-market session. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) shares increased by 40.52% to $0.24. The company's market cap stands at $10.1 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares increased by 22.03% to $1.44. The company's market cap stands at $183.6 million. </li>
<li>Universal Security (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UUU#AMEX">UUU</a>) stock rose 16.26% to $3.86. The market value of their outstanding shares is at $7.6 million. </li>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) stock moved upwards by 11.73% to $2.57. The market value of their outstanding shares is at $36.6 million. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock moved upwards by 11.51% to $0.51. The company's market cap stands at $15.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BitMine Immersion Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) stock fell 15.2% to $114.5 during Monday's pre-market session. The market value of their outstanding shares is at $818.5 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares fell 10.67% to $0.15. The company's market cap stands at $17.8 million. </li>
<li>Greenidge Generation Holdings Inc. - 8.50% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREEL#NASDAQ">GREEL</a>) stock fell 10.22% to $8.0. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) shares decreased by 8.49% to $4.1. The company's market cap stands at $3.8 million. </li>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) shares declined by 7.84% to $5.23. The company's market cap stands at $7.2 million. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) stock declined by 7.45% to $2.61. The company's market cap stands at $286.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMNR

BTCM

BTOG

BZAI

Greenidge Generation Holdings Inc. - 8.50% Senior Notes due 2026

GREEL

LCFY

SVRE

TAOP

WOLF

YAAS

12 Information Technology Stocks Moving In Monday's Pre-Market Session

$14.3 million received July 2 Additional $23.2 million expected to close in third quarter of 2025 Total funding scalable to $75 million
AUSTIN, Texas, July 07, 2025 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>), a leading provider of solar tracker systems, software and engineering services, today announced that it entered into a new $75 million strategic financing facility (the "Financing Facility") with Cleanhill Partners and affiliates, AV Securities and other long-term investors.
The Financing Facility provides for an initial term loan financing of up to $37.5 million. Of this amount, $14.3 million of term loan financing and an associated warrant issuance closed and funded on July 2, 2025. The balance of $23.2 million of the initial financing is expected to close in the third quarter of 2025, subject to shareholder approval of the maximum number of shares for which the warrants issued in connection with the Financing Facility may be exercised and the other conditions under the Financing Facility.
The Financing Facility also provides for up to an additional $37.5 million in funding to be available to the company as may be needed in the future upon mutual agreement between the company and the investors under the Financing Facility, for a total potential financing of $75 million.

Financing

FTCI

FTC Solar Announces That It Entered Into A New $75M Strategic Financing Facility With Cleanhill Partners And Affiliates, AV Securities And Other Long-Term Investors

Jefferies analyst Surinder Thind downgrades ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) from Hold to Underperform and lowers the price target from $53 to $42.

Downgrades

Price Target

ASGN

Jefferies Downgrades ASGN to Underperform, Lowers Price Target to $42

Biotech

General

URGN

UroGen Completes Enrollment In Phase 3 UTOPIA Clinical Trial Of UGN-103

LENZ Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) and Laboratoires Théa ("Théa") announced an exclusive license and commercialization agreement for Théa to register and commercialize LNZ100 for the treatment of presbyopia in Canada. LENZ Therapeutics is a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in people with presbyopia, which has a US FDA PDUFA date of August 8, 2025. Théa is an independent pharmaceutical company specialized in the research, development and commercialization of eye-care products.
Under the terms of the licensing and commercialization agreement, LENZ will be eligible to receive over $70 million in upfront, regulatory and commercial milestone payments, as well as tiered, double-digit royalties on net sales. Théa will have exclusive development, manufacturing, registration and commercialization rights for LNZ100 for the treatment of presbyopia in Canada.

LENZ

LENZ Therapeutics And Laboratoires Théa Announce Exclusive License And Commercialization Agreement For Théa To Register, Commercialize LNZ100 For Presbyopia Treatment In Canada

Nano Labs Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider in China, today announced a correction to the first paragraph of its press release entitled "Nano Labs Has Purchased About US$50 Million BNB, Expands Digital Asset Reserves to around US$160 Million" which was issued on&nbsp;July 3, 2025 (the "Original Press Release").
The correction is to the Original Press Release's first paragraph with the original version reading:
"HONG KONG, July 03, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider in China, today announced the purchase of 74,315 Binance Coin (BNB) tokens through the OTC (Over-The-Counter) format at an average price of approximately US$672.45, with a total transaction value of about US$50 million. Following this transaction, the Company's cumulative reserve of mainstream digital currencies, including Bitcoin and BNB, has around US$160 million, marking a successful initial step in Nano Labs' BNB strategic plan and underscoring its commitment to increasing BNB holdings over time."
The complete, corrected release follows:
"HONG KONG, July 03, 2025 (GLOBE NEWSWIRE) --&nbsp;Nano Labs Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider in China, today announced the purchase of 74,315 BNB tokens through the OTC (Over-The-Counter) format at an average price of approximately US$672.45, with a total transaction value of about US$50 million. Following this transaction, the Company's cumulative reserve of mainstream digital currencies, including Bitcoin and BNB, has around US$160 million, marking a successful initial step in Nano Labs' BNB strategic plan and underscoring its commitment to increasing BNB holdings over time."
The Company committed to thoroughly evaluating the security and long-term value of BNB, aiming to acquire up to US$1 billion worth of BNB through convertible notes and private placements in the initial phase. Over the long run, Nano Labs intends to hold 5% to 10% of BNB's total circulating supply.

Nano Labs Corrects Press Release On $50M BNB Purchase Issued On July 3, 2025; Reaffirms Plan To Hold 5% - 10% Of Total BNB Supply

Jefferies analyst Laurence Alexander downgrades MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) from Buy to Hold and raises the price target from $32 to $33.

Jefferies Downgrades MP Materials to Hold, Raises Price Target to $33

KIDZ

Classover Acquires IP Portfolio Related To AI-Powered Tutoring Platform, Terms Not Disclosed

Analysts' ratings for Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) over the last quarter vary from bullish to bearish, as provided by 9 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Albertsons Companies, revealing an average target of $25.0, a high estimate of $31.00, and a low estimate of $22.00. This upward trend is apparent, with the current average reflecting a 4.17% increase from the previous average price target of $24.00.
<img src="https://www.benzinga.com/files/images/story/2025/1751889814_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Albertsons Companies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$24.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Kelly Bania</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Ken Goldman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Ivan Feinseth</td>
<td>Tigress Financial</td>
<td>Raises</td>
<td>Buy</td>
<td>$28.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$22.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Mark Carden</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$24.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Joe Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$26.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Albertsons Companies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Albertsons Companies compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Albertsons Companies's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Albertsons Companies's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ACI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Albertsons Companies analyst ratings.</a>
<h2>Unveiling the Story Behind Albertsons Companies</h2>
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.
<h3>Financial Milestones: Albertsons Companies's Journey</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Albertsons Companies displayed positive results in 3M. As of 28 February, 2025, the company achieved a solid revenue growth rate of approximately 2.51%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Albertsons Companies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.91% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.09%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Albertsons Companies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.64% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Albertsons Companies's debt-to-equity ratio is notably higher than the industry average. With a ratio of 4.19, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Albertsons Companies Stands With Analysts

<ul>
<li>FDA assigns PDUFA target action date of January 5, 2026, for decision on accelerated approval</li>
<li>Tividenofusp alfa is designed to deliver missing enzyme to entire body and cross blood-brain barrier into the brain</li>
<li>Tividenofusp alfa leads company's broader TransportVehicle&#x2122;-enabled pipeline</li>
</ul>

DNLI

Denali Therapeutics Announces FDA Acceptance, Priority Review of Biologics License Application For Tividenofusp Alfa For Hunter Syndrome; Sets PDUFA Date Of Jan. 5, 2026

Buybacks

COLL

Collegium Announces $150M Share Repurchase Program

Genius Group Ltd Files For Mixed Shelf Of Up To $1.2B

U Power Signs Electric Service Provider Agreement To Facilitate Deployment Of UOTTA Battery-Swapping Stations And Sale Of Compatible EVs In Singapore

Contracts

Press Releases

Zions Bancorporation to Implement nCino Platform and Intelligent Solutions as the Technology Foundation of its Lending End-to-End Process Transformation

Banque Raiffeisen Partners with nCino for Intelligent Loan Management to Drive Credit Chain Digitalization

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of nCino, Inc. (NASDAQ: NCNO)

nCino to Host 2025 Investor Day

Fintech

Pinwheel and nCino Partner to Offer Direct Deposit Switching

nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call

nCino Unveils Transformative AI-Powered Banking Solutions at nSight 2025

nCino Announces Preliminary First Quarter Fiscal Year 2026 Financial Results Exceed Top End of Guidance

Comments

Ncino

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO